封面
市场调查报告书
商品编码
1645720

全球蛋白胨市场按来源、最终用户和应用划分 - 机会分析和产业预测,2024-2035 年

Peptone Market By Source of Peptone, By End User, By Application : Global Opportunity Analysis and Industry Forecast, 2024-2035

出版日期: | 出版商: Allied Market Research | 英文 321 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计 2023 年蛋白胨市场价值将达到 1.495 亿美元,到 2035 年将达到 2.409 亿美元,2024 年至 2035 年的复合年增长率为 4.2%。

蛋白胨是利用酵素或酸对动物、植物或微生物蛋白质源进行部分水解而获得的水溶性蛋白质衍生物。它广泛用于实验室和工业培养细菌、真菌和其他微生物。它们在药物研究、诊断和发酵过程中发挥关键作用,有助于抗生素、酵素和其他生技药品的生产。

蛋白胨市场-IMG1

由于製药、学术和医疗保健领域基于微生物学的研究不断增加,以及疫苗、抗生素和益生菌开发力度不断加大等因素,全球蛋白胨市场正经历显着成长。此外,生物技术和製药行业的扩张也为市场成长做出了巨大贡献。此外,感染疾病率的惊人上升导致全球对诊断实验室的投资增加,这是蛋白胨消费的驱动力。

根据美国全国医院感染疾病流行情况调查(2021年),光是在美国,因感染疾病和寄生虫病而到急诊室就诊的人数就达380万。其中住院患者人数预计达48.2万人。这凸显了对蛋白胨的迫切需求。此外,疫苗製造中蛋白胨的使用不断增加是全球市场的主要动力。这是因为蛋白胨是疫苗生产中使用的细菌和病毒等微生物培养培养基中的主要营养来源。这些营养丰富的蛋白质水解物提供疫苗生产过程中微生物和细胞最佳生长所需的必需胺基酸、胜肽、维生素和矿物质。全球最大的开放取用研究出版商泰勒弗朗西斯 (Taylor & Francis) 于 2021 年发表的一项研究显示,常规疫苗接种每年可挽救约 200 万至 300 万人的生命。由于蛋白胨在发酵过程中用于生产食品和饮料、乳製品和膳食补充剂,因此食品和饮料行业对蛋白胨的使用不断增加将推动未来市场的成长。

然而,製造蛋白胨所需的高成本(涉及酶水解和酸水解等复杂过程)抑制了市场的成长。此外,合成或化学定义的培养基的进步为蛋白胨提供了替代品,特别是在需要精确度和可重复性的应用中,例如用于单株抗体生产的细胞培养,从而阻碍了市场的成长。相反,全球对永续生物基产品的关注正在推动蛋白胨作为发酵营养素的应用,这有望为市场成长提供有利可图的机会。此外,人们对动物源性蛋白胨的担忧以及製药和食品应用向纯素和无动物替代品的转变为植物来源或微生物源性蛋白胨铺平了道路。

全球蛋白胨市场根据蛋白胨来源、应用、最终用户和地区进行细分。根据蛋白胨的来源,市场分为动物蛋白胨、植物蛋白胨、微生物蛋白胨和混合蛋白胨。根据最终用户,市场可分为製药和生物产业、研究机构、食品和饮料产业等。根据应用,市场分为细胞培养、发酵、食品和饮料等。按地区分析,涵盖北美、欧洲、亚太地区、拉丁美洲、中东和非洲。

主要发现

  • 根据蛋白胨的来源,动物蛋白胨部分在 2023 年占据了市场占有率的主导地位。
  • 根据最终用户,製药和生物技术产业部门是 2023 年的主要股东,预计 2024 年至 2035 年期间的复合年增长率最高。
  • 根据应用,细胞培养领域预计将在 2023 年占据最大份额,并在预测期内呈现最高的复合年增长率。
  • 按地区划分,北美是 2023 年蛋白胨市场的最大股东。

竞争分析

相关人员的主要利益

  • 该报告对 2019 年至 2035 年蛋白胨市场的细分市场、当前趋势、估计和趋势分析进行了定量分析,并确定了蛋白胨市场的主要机会。
  • 它为市场研究提供与市场驱动因素、市场限制因素和市场机会相关的资讯。
  • 波特五力分析强调了买家和供应商的潜力,使相关人员能够做出利润驱动的商业决策并加强供应商-买家网络。
  • 对蛋白胨市场细分进行详细分析有助于发现市场机会。
  • 每个地区的主要国家都根据收益贡献进行划分。
  • 市场公司的定位有利于进行对标,并能清楚了解市场公司的当前地位。
  • 报告包括区域和全球蛋白胨市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

此报告可进行客製化(需支付额外费用和时间表)

  • 国家、地区和全球层面的患者/流行病学资料
  • 监管指南
  • 根据客户兴趣提供额外的公司简介
  • 按国家或地区进行的额外分析 - 市场规模和预测
  • 扩展公司简介列表
  • 历史市场资料
  • SWOT 分析

目录

第 1 章 简介

第 2 章执行摘要

第三章 市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会

第 4 章 蛋白胨市场依来源划分

  • 概述
  • 动物蛋白胨
  • 植物蛋白胨
  • 微生物蛋白胨
  • 混合蛋白胨

第 5 章 蛋白胨市场以最终用户划分

  • 概述
  • 製药和生物技术产业
  • 研究所
  • 食品和饮料
  • 其他的

第六章 蛋白胨市场依应用

  • 概述
  • 细胞培养
  • 发酵
  • 食品和饮料
  • 其他的

第七章 蛋白胨市场(依地区)

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 澳洲
    • 印度
    • 韩国
    • 其他的
  • 拉丁美洲、中东和非洲
    • 巴西
    • 沙乌地阿拉伯
    • 南非
    • 其他的

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 前 10 家公司的产品图谱
  • 竞争仪錶板
  • 竞争热图
  • 主要企业定位(2019年)

第九章 公司简介

  • Thermo Fisher Scienctific
  • Solabia Group
  • Kerry Group plc
  • Becton, Dickinson and Company
  • HiMedia Laboratories
  • Liofilchem Srl
  • Neogen Corporation
  • Merck KGaA
  • Titan Biotech Ltd.
  • Nu-Tek BioSciences
简介目录
Product Code: A03336

The peptone market was valued at $149.5 million in 2023 and is estimated to reach $240.9 million by 2035, exhibiting a CAGR of 4.2% from 2024 to 2035.

Peptone is a water-soluble protein derivative obtained through the partial hydrolysis of animal, plant, or microbial protein sources using enzymes or acids. They are widely used in laboratories and industries for cultivating bacteria, fungi, and other microorganisms. They play a crucial role in pharmaceutical research, diagnostics, and fermentation processes, contributing to the production of antibiotics, enzymes, and other biologics.

Peptone Market - IMG1

The global peptone market is witnessing notable growth due to factors such as increase in microbiology-based research in pharmaceutical, academic, and healthcare sectors and rise in efforts to develop vaccines, antibiotics, and probiotics. Furthermore, expansion of biotechnology and pharmaceutical industries significantly contributes toward the market growth. Moreover, alarming rise in prevalence of infectious diseases has resulted in increased investment in diagnostic labs globally, which, in turn, drives the consumption of peptones.

According to the prevalence of infectious diseases National Hospital Ambulatory Medical Care Survey: 2021, the number of emergency department visits due to infectious and parasitic diseases was recorded to be 3.8 million in the U.S. alone. Among these, hospital admissions were estimated to reach 482,000. This emphasizes the urgent need for peptone. In addition, increase in use of peptones in vaccine productions acts as a key driving force of the global market. This is attributed to the fact that peptones serves as the primary nutrient source in the growth media for culturing microorganisms, such as bacteria or viruses, that are used to produce vaccines. These nutrient-rich protein hydrolysates provide essential amino acids, peptides, vitamins, and minerals necessary for optimal microbial or cell growth during vaccine manufacturing. A 2021 study published by Taylor & Francis-one of the world's largest publishers of open access research revealed that approximately 2-3 million lives are saved every year due to routine vaccination. Rise in application of peptones in the food & beverages industry future fuels the market growth, as they are used in the fermentation processes for the production of beverages, dairy products, and dietary supplements.

However, high cost associated with manufacturing of peptones, which involves complex processes such as enzymatic or acid hydrolysis, restrains the market growth. In addition, advances in synthetic and chemically defined media are offering alternatives to peptones, particularly in applications requiring precision and reproducibility, such as cell culture for monoclonal antibody production, thereby hampering the market growth. On the contrary, the global focus on sustainable bio-based products supports the adoption of peptones as fermentation nutrients, which is expected to offer lucrative opportunities for the market growth. Moreover, concerns over animal-derived peptones and a shift toward vegan and animal-free alternatives in pharmaceuticals and food applications have opened new avenues for plant-based or microbial peptones.

The global peptone market is segmented into source of peptone, application, end user, and region. By source of peptone, the market is divided into animal peptone, plant peptone, microbial peptone, and mixed peptone. On the basis of end user, it is segregated into pharmaceutical & biotech industry, research institutions, food & beverage industry, and others. Depending on application, it is categorized into cell culture, fermentation, food & beverages, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

  • On the basis of source of peptone, the animal peptone segment dominated the market share in 2023.
  • Depending on end user, the pharmaceutical & biotech industry segment was the major shareholder in 2023, and is expected to grow at the highest CAGR from 2024 to 2035.
  • By application, the cell culture segment garnered the largest share in 2023, and is anticipated to exhibit the highest CAGR during the forecast period
  • Region wise, North America was the largest shareholder in the peptone market in 2023.

Competitive Analysis

The key players that operate in the global peptone market are Thermo Fisher Scientific Inc., Solabia Group, Kerry Inc, Nu-Tek Biosciences, Becton Dickinson and Company, Himedia Laboratories, Liofilchem S.R.L, Neogen Corporation, Merck KGaA, and Titan Biotech Ltd. These players have adopted acquisition, agreement, collaboration, joint venture, partnership, and product launch as their key developmental strategies to sustain the intense competition and gain a strong foothold in the global market.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the peptone market analysis from 2019 to 2035 to identify the prevailing peptone market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the peptone market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global peptone market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Source of Peptone

  • Animal Peptone
  • Plant Peptone
  • Microbial Peptone
  • Mixed Peptone

By End User

  • Pharmaceutical and Biotech Industry
  • Research Institutions
  • Food and Beverage Industry
  • Others

By Application

  • Cell Culture
  • Fermentation
  • Food and Beverages
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Kerry Group plc
    • Becton, Dickinson and Company
    • HiMedia Laboratories
    • Neogen Corporation
    • Merck KGaA
    • Solabia Group
    • Titan Biotech Ltd.
    • Thermo Fisher Scienctific
    • Liofilchem S.r.l
    • Nu-Tek BioSciences

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: PEPTONE MARKET, BY SOURCE OF PEPTONE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Animal Peptone
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Plant Peptone
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Microbial Peptone
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Mixed Peptone
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: PEPTONE MARKET, BY END USER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Pharmaceutical and Biotech Industry
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Research Institutions
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Food and Beverage Industry
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: PEPTONE MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Cell Culture
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Fermentation
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Food and Beverages
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Others
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country

CHAPTER 7: PEPTONE MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Source of Peptone
    • 7.2.3. Market size and forecast, by End User
    • 7.2.4. Market size and forecast, by Application
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Source of Peptone
      • 7.2.5.1.2. Market size and forecast, by End User
      • 7.2.5.1.3. Market size and forecast, by Application
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Source of Peptone
      • 7.2.5.2.2. Market size and forecast, by End User
      • 7.2.5.2.3. Market size and forecast, by Application
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Source of Peptone
      • 7.2.5.3.2. Market size and forecast, by End User
      • 7.2.5.3.3. Market size and forecast, by Application
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Source of Peptone
    • 7.3.3. Market size and forecast, by End User
    • 7.3.4. Market size and forecast, by Application
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Source of Peptone
      • 7.3.5.1.2. Market size and forecast, by End User
      • 7.3.5.1.3. Market size and forecast, by Application
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Source of Peptone
      • 7.3.5.2.2. Market size and forecast, by End User
      • 7.3.5.2.3. Market size and forecast, by Application
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Source of Peptone
      • 7.3.5.3.2. Market size and forecast, by End User
      • 7.3.5.3.3. Market size and forecast, by Application
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Source of Peptone
      • 7.3.5.4.2. Market size and forecast, by End User
      • 7.3.5.4.3. Market size and forecast, by Application
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Source of Peptone
      • 7.3.5.5.2. Market size and forecast, by End User
      • 7.3.5.5.3. Market size and forecast, by Application
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Source of Peptone
      • 7.3.5.6.2. Market size and forecast, by End User
      • 7.3.5.6.3. Market size and forecast, by Application
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Source of Peptone
    • 7.4.3. Market size and forecast, by End User
    • 7.4.4. Market size and forecast, by Application
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Source of Peptone
      • 7.4.5.1.2. Market size and forecast, by End User
      • 7.4.5.1.3. Market size and forecast, by Application
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Source of Peptone
      • 7.4.5.2.2. Market size and forecast, by End User
      • 7.4.5.2.3. Market size and forecast, by Application
      • 7.4.5.3. Australia
      • 7.4.5.3.1. Market size and forecast, by Source of Peptone
      • 7.4.5.3.2. Market size and forecast, by End User
      • 7.4.5.3.3. Market size and forecast, by Application
      • 7.4.5.4. India
      • 7.4.5.4.1. Market size and forecast, by Source of Peptone
      • 7.4.5.4.2. Market size and forecast, by End User
      • 7.4.5.4.3. Market size and forecast, by Application
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Source of Peptone
      • 7.4.5.5.2. Market size and forecast, by End User
      • 7.4.5.5.3. Market size and forecast, by Application
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Source of Peptone
      • 7.4.5.6.2. Market size and forecast, by End User
      • 7.4.5.6.3. Market size and forecast, by Application
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Source of Peptone
    • 7.5.3. Market size and forecast, by End User
    • 7.5.4. Market size and forecast, by Application
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Source of Peptone
      • 7.5.5.1.2. Market size and forecast, by End User
      • 7.5.5.1.3. Market size and forecast, by Application
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Source of Peptone
      • 7.5.5.2.2. Market size and forecast, by End User
      • 7.5.5.2.3. Market size and forecast, by Application
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Source of Peptone
      • 7.5.5.3.2. Market size and forecast, by End User
      • 7.5.5.3.3. Market size and forecast, by Application
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Source of Peptone
      • 7.5.5.4.2. Market size and forecast, by End User
      • 7.5.5.4.3. Market size and forecast, by Application

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2019

CHAPTER 9: COMPANY PROFILES

  • 9.1. Thermo Fisher Scienctific
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. Solabia Group
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Kerry Group plc
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.7. Key strategic moves and developments
  • 9.4. Becton, Dickinson and Company
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
    • 9.4.7. Key strategic moves and developments
  • 9.5. HiMedia Laboratories
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
    • 9.5.7. Key strategic moves and developments
  • 9.6. Liofilchem S.r.l
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. Neogen Corporation
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
    • 9.7.7. Key strategic moves and developments
  • 9.8. Merck KGaA
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
    • 9.8.7. Key strategic moves and developments
  • 9.9. Titan Biotech Ltd.
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
    • 9.9.7. Key strategic moves and developments
  • 9.10. Nu-Tek BioSciences
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance
    • 9.10.7. Key strategic moves and developments